Literature DB >> 28510699

Invasive Pneumococcal Disease in Infants Aged 0-60 Days in the United States in the 13-Valent Pneumococcal Conjugate Vaccine Era.

Liset Olarte1, William J Barson2, John S Bradley3, Tina Q Tan4, Philana Ling Lin5, José R Romero6, Laurence B Givner7, Jill A Hoffman8, Kristina G Hultén1, Edward O Mason1, Sheldon L Kaplan1.   

Abstract

We identified 53 infants aged 0-60 days with invasive pneumococcal disease (IPD) at 8 children's hospitals in the United States (2005-2015). After the introduction of 13-valent pneumococcal conjugate vaccine (PCV13), IPD caused by PCV13 serotypes decreased ~30% providing some evidence of indirect protection. However, approximately 60% of IPD was still caused by PCV13 serotypes.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 28510699     DOI： 10.1093/jpids/pix034

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN： 2048-7193            Impact factor:   3.164


  3 in total

Review 1.  Prevention of Invasive Pneumococcal Disease: Problems Emerged After Some Years of the 13-Valent Pneumococcal Conjugate Vaccine Use.

Authors:  Nicola Principi; Giuseppe Di Cara; Ilaria Bizzarri; Chiara Isidori; Paola Borgia; Costanza Mignini; Marco Saponara; Alberto Argentiero; Susanna Esposito
Journal:  Curr Infect Dis Rep       Date:  2018-01-24       Impact factor: 3.725

Review 2.  Epidemiology of non-vaccine serotypes of Streptococcus pneumoniae before and after universal administration of pneumococcal conjugate vaccines.

Authors:  Qian-Qian Du; Wei Shi; Dan Yu; Kai-Hu Yao
Journal:  Hum Vaccin Immunother       Date:  2021-11-02       Impact factor: 3.452

3.  Clinical implications of aminotransferase elevation in hospitalised infants aged 8-90 days with respiratory virus detection.

Authors:  Sang Gyeom Kim; Yu Na Oh; Joon Kee Lee
Journal:  Influenza Other Respir Viruses       Date:  2020-03-10       Impact factor: 4.380
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.